Table 1 Overall comparison of the sociodemographic and clinical characteristics of patients with SCSTs versus GCTs
| Factor | Overall cohort | SCSTs | GCTs | p-value |
|---|---|---|---|---|
| N | 42,192 | 280 | 41,912 | |
| Age at diagnosis, median (IQR) | 34 (27, 43) | 45 (34, 59) | 34 (27, 43) | < 0.001 |
| Diagnosis year | 0.002 | |||
| 2004–2005 | 8215 (20%) | 48 (17%) | 8167 (20%) | |
| 2006–2007 | 8329 (20%) | 39 (14%) | 8290 (20%) | |
| 2008–2009 | 8520 (20%) | 50 (18%) | 8470 (20%) | |
| 2010–2011 | 8561 (20%) | 81 (29%) | 8480 (20%) | |
| 2012–2013 | 8567 (20%) | 62 (22%) | 8505 (20%) | |
| Race/ethnicity | < 0.001 | |||
| Non-Hispanic White | 32,565 (77%) | 174 (62%) | 32,391 (77%) | |
| Non-Hispanic Black | 1168 (3%) | 48 (17%) | 1120 (3%) | |
| Hispanic/Other | 7727 (18%) | 55 (20%) | 7672 (18%) | |
| Unknown | 732 (2%) | 3 (1%) | 729 (2%) | |
| Insurance | < 0.001 | |||
| Uninsured | 4786 (11%) | 24 (9%) | 4762 (11%) | |
| Private insurance | 31,092 (74%) | 178 (64%) | 30,914 (74%) | |
|
Medicaid/Medicare/other government insurance | 5487 (13%) | 70 (25%) | 5417 (13%) | |
| Unknown | 827 (2%) | 8 (3%) | 819 (2%) | |
| Income (per year) | 0.42 | |||
| Less than $38 k | 5533 (13%) | 45 (16%) | 5488 (13%) | |
| $38 k-62,999 | 20,324 (48%) | 125 (45%) | 20,199 (48%) | |
| $63 k or greater | 15,769 (37%) | 106 (38%) | 15,663 (37%) | |
| Unknown | 566 (1%) | 4 (1%) | 562 (1%) | |
| Percent in ZIP code without a high school degree | 0.81 | |||
| 21% or greater | 6203 (15%) | 42 (15%) | 6161 (15%) | |
| 7–20.9% | 23,172 (55%) | 159 (57%) | 23,013 (55%) | |
| Less than 7% | 12,287 (29%) | 75 (27%) | 12,212 (29%) | |
| Unknown | 530 (1%) | 4 (1%) | 526 (1%) | |
| Residence | 0.48 | |||
| Metropolitan | 35,048 (83%) | 237 (85%) | 34,811 (83%) | |
| Urban/rural | 7144 (17%) | 43 (15%) | 7101 (17%) | |
| Charlson-Deyo comorbidity score | 0.001 | |||
| 0 | 39,825 (94%) | 252 (90%) | 39,573 (94%) | |
| 1 or more | 2367 (6%) | 28 (10%) | 2339 (6%) | |
| Stage | < 0.001 | |||
| Stage I | 32,463 (77%) | 259 (93%) | 32,204 (77%) | |
| Stage II | 5478 (13%) | 9 (3%) | 5469 (13%) | |
| Stage III | 4251 (10%) | 12 (4%) | 4239 (10%) | |
| Treatment received | < 0.001 | |||
| No orchiectomy | 666 (2%) | 2 (0.7%) | 664 (2%) | |
| Orchiectomy alone | 17,885 (42%) | 260 (93%) | 17,625 (42%) | |
| Orchiectomy + adjuvant therapy | 23,585 (56%) | 18 (6%) | 23,567 (56%) | |
| Other/unknown | 56 (0.1%) | 0 (0%) | 56 (0.1%) | |
| Last contact or death, months from diagnosis, median (IQR) | N = 37,716 | N = 249 | N = 37,467 | |
| 52 (28, 79) | 39 (20, 61) | 52 (28, 79) | < 0.001 | |
| Time from diagnosis to death in months, median (IQR) | N = 1640 | N = 27 | N = 1613 | |
| 20 (7, 43) | 18 (7, 37) | 20 (7, 43) | 0.88 |